Dopa-responsive dystonia due to sepiapterin reductase deficiency

Sepiapterin reductase deficiency (SRD) is a rare inherited brain disorder that affects how the body makes important chemical messengers called neurotransmitters — specifically dopamine and serotonin. These chemicals help control movement, mood, sleep, and many other body functions. The disease is also sometimes called dopa-responsive dystonia due to sepiapterin reductase deficiency, or simply SR deficiency. It belongs to a group of conditions known as tetrahydrobiopterin (BH4) deficiencies. The condition mainly affects the nervous system. Because the brain cannot make enough dopamine and serotonin, children with SRD develop problems with movement, muscle tone, and development. The most noticeable symptoms include abnormal, involuntary muscle contractions (called dystonia), stiffness, difficulty walking, and delays in reaching milestones like sitting or standing. Many children also have intellectual disability, mood changes, and sleep problems. The good news is that SRD responds well to treatment. Replacing the missing neurotransmitters with medications — especially levodopa (L-dopa) combined with carbidopa — can dramatically improve symptoms. Some children show remarkable improvement with treatment. Early diagnosis and starting therapy as soon as possible are very important for the best outcome. Lifelong treatment is usually needed, but many patients can lead meaningful, active lives with proper care.

Bring these to your next appointment

• Q1.What dose of levodopa/carbidopa should my child start on, and how will we know if it is working?,Should we also add 5-HTP or folinic acid to the treatment plan?,How often should we check cerebrospinal fluid or blood tests to monitor treatment?,What signs should prompt us to go to the emergency room?,Will my child's intellectual development improve with treatment, or are there other therapies we should start?,Are there any clinical trials or research studies we should know about?,Should other family members be tested for the SPR gene mutation?

Common questions about Dopa-responsive dystonia due to sepiapterin reductase deficiency